Tirzepatide 15mg
GLP-1 + GIP Dual Agonist · Mounjaro / Zepbound reference
4 mechanisms. One peptide.
What this peptide does at the cellular level, in plain words.
GLP-1 activation
Receptor agonist with greater potency than semaglutide in some models.
GIP activation
Dual agonism: also activates GIP receptor. Synergizes metabolic action.
Enhanced satiety
Dual mechanism amplifies appetite suppression vs mono-agonists.
Recomposition
Reports of up to 22.5% body weight loss in phase III studies.
Stacks. What to pair it with.
Peptides often synergize. These are the most studied combinations with this product, and what outcome they target.
BPC-157
Loss + GI protection
Reduces nausea during initial titration.
CJC-1295 + Ipa
Cut + preserved muscle
Endogenous anabolism while in caloric deficit.
TB-500
Definition + recovery
TB-500 accelerates training adaptation during cutting.
Any combination must respect each peptide's protocol. If you have doubts about dosing or timing, message us before starting.
Technical description
Tirzepatide is a synthetic dual agonist peptide targeting both GLP-1 and GIP receptors simultaneously, distinguishing it from single-receptor metabolic peptides like semaglutide. As the active molecule in Mounjaro and Zepbound, tirzepatide has been characterized in over 100 clinical and preclinical studies for its effects on glycemic control, body composition, and energy expenditure.
SuperBio Labs Tirzepatide is supplied as lyophilized powder with ≥99% HPLC-verified purity. Each lot ships with a third-party Certificate of Analysis confirming peptide identity by LC-MS, peptide content, and endotoxin levels.
The dual receptor mechanism is what makes tirzepatide a critical reference compound in metabolic research: GLP-1 activation modulates appetite and glucose-dependent insulin secretion, while concurrent GIP activation enhances insulin sensitivity and lipid metabolism.
For Research Use Only.
Your complete kit, ready to apply.
We don't just hand you the vial. Every Tirzepatide purchase includes everything you need to apply it safely, with a clear protocol and our team available 24/7.
Tirzepatide vial
Lyophilized · HPLC purity ≥99% · Batch with COA
Bacteriostatic water 30ml
Sterile diluent · 0.9% benzyl alcohol
1 extraction syringe 3ml
21G needle · For peptide reconstitution
5–10 insulin syringes (29G)
10mg → 5 · 20mg → 10 · 1×/week
10–20 alcohol wipes 70%
10mg → 10 · 20mg → 20 · 2 per application (vial + skin)
Printed protocol
Physical document · Reconstitution and dosing
Visual step-by-step guide
8 steps · From opening the kit to application
SuperBio OS · Support
App · Tracking · Human team 24/7
About supplies: the quantity of syringes and wipes adjusts automatically based on the presentation you choose. For extended cycles (BPC-157, GHK-Cu and similar) we cap supplies at 30 days — beyond that, 29G insulin syringes and 70% alcohol wipes are pharmacy items available without prescription in any city.
Recommended application protocol.
This is the conservative protocol included in the kit. We send it printed and digital, along with your access to SuperBio OS for tracking and support. If you have pre-existing medical conditions, consult a professional before starting.
Recommended titration
Wk 1–4: 2.5mg → Wk 5–8: 5mg → Wk 9–12: 7.5mg → Wk 13–16: 10–15mg
Dual GLP-1 + GIP agonist. Same day each week.
Technical specifications
| Product | Tirzepatide |
| CAS Number | 2023788-19-2 |
| Molecular Weight | 4813.45 Da |
| Purity (HPLC) | ≥99% |
| Format | Lyophilized powder |
| Quantity | 15mg per vial |
| Endotoxin | <1.0 EU/mg |
| Storage | −20 °C, protected from light |
| Use | Research Use Only (RUO) |